Association of Extended Dosing Intervals or Delays in Pembrolizumab-Based Regimens With Survival Outcomes in Advanced Non-small-cell Lung Cancer

Authors
Publication date
1 January 2023
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    The University of North Carolina at Greensboro

    redirect
    oaioai:libres.uncg.edu/42081
    Last time updated on 18/07/2023